DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20173585

Role of topical steroid in primary treatment of childhood phimosis

Sanjay Changole, Smita Dhane, Nilesh Agrawal

Abstract


Background: Circumcision has been the traditional treatment for phimosis, but with some controversies due to complications. The current study was undertaken to evaluate the effectiveness of topical steroid therapy as primary treatment for childhood phimosis.

Methods: A prospective observational study was conducted and a total of 100 patients (age- 3 to 12 years) of phimosis were enrolled. The management consisted of topical application of 0.05% betamethasone Ointment for 4 weeks. Those with partial response were advised additional 2 weeks of therapy. Failure to treatment cases were subsequently subjected to circumcision.

Results: Total 100 patients were enrolled in the study. Out of 100 patients, 9 were excluded because of non-compliance and remaining 91 patients were studied and followed up. 85 cases out of 91 (93.4%) were declared a ‘success’; while remaining 6 (6.6%) were declared ‘failure’ and were subjected to circumcision. Of the 85 successfully treated; majority (70, 82.3%) responded within 4 weeks of treatment and 15 (17.6%) responded in 6 weeks. The highest number of patients who responded to treatment within 4 weeks were < 5 years of age (54, 93.1%) (p<0.05).

Conclusions: Topical steroid (0.05% betamethasone ointment) is an effective, safe, conservative and non-surgical method of primary treatment of childhood Phimosis, especially when combined with good hygiene practices of foreskin with daily retraction and cleansing.


Keywords


Phimosis, Steroid, Betamethasone

Full Text:

PDF

References


Gairdner D. The fate of foreskin. Br Med J. 1949;2:1433.

Oster J. Further fate of the foreskin. Arch Dis Child. 1968; 43:200-3.

Whitfield HN, Frank JD, William G. The prepuce. BJU Int. 1999;83(1):1-113.

William N, Kapila L. Complications of circumcision. Brit J Surg. 1993;80:1231-6.

Orsola A, Caffaratti J, Garat JM. Conservative treatment of phimosis in children using topical steroid. Urol. 2000;56:307-10.

Kayaba H, Tamura H, Kitajima S. Fujiwara Y, Kato T. Analysis of shape and retractability of the prepuce in 603 Japanese boys. J Uro. 1996;156:1813-5.

Monsour MA, Rabinovitch HH, Dean GE. Medical management of phimosis in children: our experience with topical steroids. J Urol. 1999;162:1162-4.

Nzayisenga JBM, Munkonge L, Labib M. Treatment of phimosis with topical steroids as an alternative to circumcision. East Central J Surg. 2005;10(2):63-6.

Tatiana C, Marques A. Treatment of phimosis with topical steroids and foreskin anatomy. Int Braz J Uro. 2005;3(4):45-8.

Griffiths D, Frank JD. Inappropriate circumcision referrals by GPs. J R Soc Med. 1992;85:324-5.

William N, Chell J, Kapila L. Why are children referred for circumcision? BMJ. 1993;306:28.

Stenram A, Malmfors G. Circumcision for phimosis: indications and results. Aeta Peta Scan. 1986;75:321-3.

Zampieri N, Corroppolo M. Phimosis and topical steroids: new clinical findings. Pediatr Surg Int. 2007;23:331-5.

Golubovic Z, Milanovic D, Viladompvoc V, Rakic I, Perovic S. The conservative treatment of phimosis in boys. Br J Urol. 1996;78:786-8.

Ku WH, Chiu BS, Huen KF. Outcome and recurrence in treatment of phimosis using topical betamethasone in children in Hong Kong. J Paed Child Health. 2007;43(1‐2):74-9.

Ruud E, Holt J. Phimosis can be treated with local steroids. J Norwegian Laege Association. 1997;117(4):513-6.